Literature DB >> 508159

Spongy degeneration of the CNS: an instance of the rare juvenile form.

W W Goodhue, R D Couch, H Namiki.   

Abstract

To our knowledge, the juvenile form of spongy degeneration of the CNS (SD-CNS); van Bogaert-Bertrand disease) has been described previously only three times. We report the case of 21 1/4-year-old Japanese woman who was first seen at the age of 11 with growth retardation, ptosis, and ophthalmoplegia. Her progressive neurodegenerative disease included retinitis pigmentosa, blindness, partial deafness, cerebellar dysfunction, hyporeflexia, and muscle wasting. Simultaneous endocrine defects were diabetes mellitus and probable hyperaldosteronism. Heart block developed later. She died of bronchopneumonia. Autopsy showed CNS stigmas typical of spongy degeneration. Additional findings included peripheral nerve demyelination, neurogenic muscle atrophy, pituitary and pancreatic atrophy, right adrenal agenesis, and a left adrenal coritcal lipid-cell adenoma. To our knowledge, our patient was the oldest survivor, the first patient of Japanese ancestry, and had a unique concurrence of certain oculoendocrine defects.

Entities:  

Mesh:

Year:  1979        PMID: 508159     DOI: 10.1001/archneur.1979.00500440051009

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  3 in total

1.  Kearns syndrome: a heterogeneous group of disorders with CPEO, or a nosological entity?

Authors:  L A Bastiaensen; C W Frenken; H J Ter Laak; H H Jaspar; A M Stadhouders; W Ruitenbeek; J H Veerkamp
Journal:  Doc Ophthalmol       Date:  1982-01-29       Impact factor: 2.379

2.  Ophthalmoplegia plus, an electro-oculographic study.

Authors:  G Marconi; P Pagnini; P Vannucchi
Journal:  Ital J Neurol Sci       Date:  1985-12

3.  The molecular basis of canavan (aspartoacylase deficiency) disease in European non-Jewish patients.

Authors:  A Shaag; Y Anikster; E Christensen; J Z Glustein; A Fois; H Michelakakis; F Nigro; E Pronicka; A Ribes; M T Zabot
Journal:  Am J Hum Genet       Date:  1995-09       Impact factor: 11.025

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.